Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $111,646 - $129,172
-3,091 Reduced 3.2%
93,443 $3.43 Million
Q1 2023

Apr 18, 2023

BUY
$39.39 - $51.28 $3.46 Million - $4.5 Million
87,773 Added 1001.86%
96,534 $3.94 Million
Q4 2022

Jan 31, 2023

SELL
$41.75 - $54.5 $6,304 - $8,229
-151 Reduced 1.69%
8,761 $449,000
Q3 2022

Oct 31, 2022

SELL
$43.76 - $53.42 $6.57 Million - $8.02 Million
-150,047 Reduced 94.39%
8,912 $390,000
Q2 2022

Aug 01, 2022

BUY
$46.53 - $55.17 $1.28 Million - $1.52 Million
27,592 Added 21.0%
158,959 $8.33 Million
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $6.01 Million - $7.45 Million
131,367 New
131,367 $6.8 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $351,535 - $447,007
-10,503 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $9,271 - $10,877
-292 Reduced 2.7%
10,503 $385,000
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $12,740 - $15,456
-423 Reduced 3.77%
10,795 $353,000
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $28,165 - $40,242
-1,042 Reduced 8.5%
11,218 $366,000
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $403,599 - $458,033
12,260 New
12,260 $480,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Leuthold Group, LLC Portfolio

Follow Leuthold Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leuthold Group, LLC with notifications on news.